The pharma company raised its guidance on revenue growth from its key treatments and expected drug launches, and now anticipates annual currency-adjusted sales to grow by 6% through 2028.
Related Posts
Microsoft Stock Drops After Slight Miss in Cloud Growth
Sales for Microsoft’s main cloud business fell just short of expectations last quarter, causing the tech giant’s stock to tumble during after-hours trading amid investor […]
Incoming Starbucks CEO’s Tall Order: Calming Anxious Employees
Brian Niccol takes over Monday amid turbulent times for the coffee giant.
How the Justice Department Is Changing Its Tactics on Cybercrime
The assistant U.S. attorney general for national security outlines where the biggest threats are coming from—and what kinds of attacks are most worrisome